In addition, lncRNA RHO GTPase-activating kinase 5 (ARHG AP5)-AS1 recruits METTL3 to enhance the stability of AR HGAP5 mRNA, leading to poor prognosis and chemotherapy resistance in GC [106]. This evidence concerns the gene METTL3 and gastric cancer.